Treatment of hypertension in patients 80 years of age or older

Minerva Medica

Volumn 100, Issue 1, 2009, Pages 25-38

  O'Rourke, M F ^a,b   Namasivayam, M ^a   Adji, A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT'S CLINIC   (Australia)

Author keywords

Aged; Antihypertensive agents; Blood pressure

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; AMLODIPINE PLUS BENAZEPRIL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GANGLION BLOCKING AGENT; INDAPAMIDE PLUS PERINDOPRIL; LOSARTAN; NITRIC ACID DERIVATIVE; PLACEBO; RAMIPRIL; RENIN INHIBITOR;

ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; BLOOD PRESSURE MEASUREMENT; BRAIN; CLINICAL TRIAL; DRUG EFFECT; DRUG RESPONSE; ELASTICITY; GERIATRIC DISORDER; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY; LOW DRUG DOSE; MICROVASCULATURE; PULSE PRESSURE; PULSE WAVE; REVIEW; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; UNSPECIFIED SIDE EFFECT;

EID: 66449131140     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Levy D, Brink S. A Change of Heart. New York: Vintage Books; 2005.
2. th, Wong ND, Larson MG, Weber MA, Kannel WB et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-315
3. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-69
4. National Heart Foundation of Australia Report. Heart and stroke facts. Canberra: National Heart foundation of Australia; 1999.
5. Uiterwaal CSPM, Anthony S, Launer LJ, Witteman JCM, Trouwborst AMW, Hofman A et al. Birth weight, growth, and blood pressure. Hypertension 1997;30:267-271
6. Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese population. Int J Cardiol 1995;52:39-44.
7. Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003. J Am Coll Cardiol 2008;52:71-79
8. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005;294:466-472 (Pubitemid 41124179)
9. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensions. Hypertension 2001;37:869-874.
10. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264
11. Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet 1999;353:793-796
12. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-1898
13. Riva-Rocci S. Un nuovo sfigmomanometro. Gazz Med Torino. 1896;47:981-96, 1001-17.
14. In: Ruskin A. Classics in arterial hypertension. Illinois: Thomas Springfield; 1956. p. 104-125
15. Korotkoff NS. A contribution to the problem of methods for the determination of blood pressure. Izvestie Imp. Voiennomedicinskoi Akademii (Rep Imperial Milit-Med Acad St Petersburg) 1905;11:365-7.
16. In: Classics in arterial hypertension. Ruskin A. Illinois: Thomas Springfield; 1956. p. 127-133
17. Mahomed FA. On the sphygmographic evidence of artero-capillary fibrosis. Trans Path Soc 187728:394-397
18. O'Rourke MF. Frederick Akbar Mahomed: historical perspective. Hypertension 1992;19:212-217
19. rd edition. Edinburgh: Young J. Pentland; 1898. p.770-776.
20. Broadbent W. The pulse. London: Cassell; 1890.
21. Mackenzie J. The study of the pulse: arterial, venous and hepatic, and of the movements of the heart. Edinburgh: Young J. Pentland; 1902.
22. Murrell W. Nitroglycerine as a remedy for angina pectoris. Lancet 1879;80:80-1; 113-5; 151-2; 225-227
23. Postel-Vinay N. A century of arterial hypertension, 1896-1996. Chichester: John Wiley & Sons; 1996.
24. rd edition. London: Oxford University Press; 1926.
25. Dustan HP. Isolated systolic hypertension: a long-neglected cause of cardiovascular complications. Am J Med 1989;86:368-369 (Pubitemid 19103900)
26. Messerli FH. Occasional notes: This day 50 years ago. N Engl J Med 1995;332:1038-1039
27. nd edition. London: Churchill; 1968.
28. Patel AB, Kostis JB, Wilson AC, Shea ML, Pressel SL, Davis BR. Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen year follow-up of the Systolic Hypertension in the Elderly Program. Stroke 2008;39:1084-1089
29. Byrom F. The hypertensive vascular crisis: an experimental study. London: Heinemann; 1969.
30. Ledingham JM. The vascular fault in hypertension: Byrom's work revisited. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. New York: Raven; 1995. p. 37-53.
31. Kannell WB, Gordon T, Schwartz MJ. Systolic vs diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 1971;27:335-46.
32. Kannell WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA 1981;245:1225-1229 (Pubitemid 11113849)
33. Messerli FH, Ventura HO, Amodeo C. Osier's maneuver and pseudohypertension. N Engl J Med 1985;312:1548-1551
34. O'Rourke MF, Vlachopoulos C, Graham R. Spurious systolic hypertension in youth. Vasc Med 2000;5:141-145
35. th edition. London: Arnold; 2005.
36. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187
37. Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V et al. for the ACCOMPLISH Trial Investigators. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients. N Engl J Med 2008;359:2417-2428
38. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D et al.; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006;113:1213-1225
39. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging. J Am Coll Cardiol 2007;50:1-13.
40. Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983;68:50-58
41. Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985;71:202-210
42. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries a 'set up' for vascular disease. Circulation 2003;107:139-146
43. Sugawara J, Hayashi K, Yokoi T, Tanaka H. Age-associated elongation of the ascending aorta. J Am Coll Cardiol Img 2008;1:739-748
44. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 2003; 107:346-354
45. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: Cellular and molecular clues to heart and arterial aging. Circulation 2003;107:490-497
46. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004;43:1239-1245
47. Taylor MG. Wave-travel in a non-uniform transmission line, in relation to pulses in arteries. Phys Med Biol 1965;10:539-550
48. Taylor MG. Wave transmission through an assembly of randomly branching elastic tubes. Biophys J 1966;6:697-716.
49. O'Rourke MF, Taylor MG. Vascular impedance of the femoral bed. Circ Res 1966;18:126-139
50. Taylor MG. The input impedance of an assembly of randomly branching elastic tubes. Biophys J 1966;6:29-51.
51. Murgo JP, Westerhof N, Giolma JP, Altobelli SA. Aortic input impedance in normal man: relationship to pressure wave forms. Circulation 1980;62:105-116 (Pubitemid 10083104)
52. Merrillon JP, Motte G, Masquet C, Azancot I, Guiomard A, Gourgon R. Relationship between physical properties of the arterial system and left ventricular performance in the course of aging and arterial hypertension. Eur Heart J 1982;3(Suppl A):95-102. (Pubitemid 12069398)
53. Kelly R, Hayward C, Avolio A, O'Rourke M. Non-invasive determination of age-related change in the human arterial pulse. Circulation 1989;80:1652-1659 (Pubitemid 20031695)
54. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR, on behalf of the ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005;46:1753-1760 (Pubitemid 41531635)
55. Wojciechowska S, Staessen JA, Nawrot T, Cwynar M, Seidlerova J, Stolarz K et al. Reference values in White Europeans for the arterial pulse wave recorded by means of the SphygmoCor device. Hypertens Res 2006;29:475-483
56. Marey EJ. Circulation du Sang. Paris: E Martinet; 1863.
57. Mahomed FA. The physiology and clinical use of the sphygmograph. Med Times Gazz 1872;1:62-64
58. Mitchell GF, Conlin PR, Dunlap ME, Lacourciere Y, Arnold MO, Ogilvie RI et al. Aortic diameter, wall stiffness, and wave reflection in systolic hypertension. Hypertension 2008;51:105-111
59. Vasan RS. Pathogenesis of elevated peripheral pulse pressure: some reflections and thinking forward. Hypertension 2008;51:33-36
60. O'Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension 2005;45:652-658 (Pubitemid 40418361)
61. Adji A, O'Rourke MF, Avolio AP. Disparate effect of ageing in pressure and flow waveform: a modelling study. Hypertension 2008 (HBPRCA abstract in press).
62. Westerhof N, O'Rourke MF Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens 1995;13:943-952
63. Miyashita H, Ikeda Y, Tsuruya Y, Sekiguchi H, Shimada K, Yaginuma T. Noninvasive evaluation of the influence of aortic wave reflection on left ventricular ejection during auxotonic contraction. Heart Vessels 1994;9:30-39 (Pubitemid 24009671)
64. Namasivayam N, Adji A, O'Rourke MF. Mechanisms for change in aortic augmentation in age. Hypertension 2008 (HBPRCA abstract in press).
65. Ingelsson E, Pencina MJ, Levy D, Aragam J, Mitchell GF, Benjamin EJ, Vasan RS. Aortic root diameter and longitudinal blood pressure tracking. Hypertension 2008;52:473-477
66. Beohar N, Erdogan A, Lee DC, Sabbah HN, Kern MJ, Teerlink J et al. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol 2008;52:13-16
67. Ferro G, Duilio C, Spinelli L, Liucci GA, Mazza F, Indolfi C. Relation between diastolic perfusion time and coronary artery stenosis during stress-induced myocardial ischemia. Circulation 1995;92:342-347
68. Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen M et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006;113:2744-2753
69. O'Rourke MF. Steady and pulsatile energy losses in the systemic circulation under normal conditions and in simulated arterial disease. Cardiovasc Res 1967;1:313-26.
70. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005;46:200-204 (Pubitemid 40946514)
71. Henry Feugeas MC, De Marco G, Peretti II, Godon-Hardy S, Fredy D, Claeys ES. Age-related cerebral white matter changes and pulse-wave encephalopathy: observations with three-dimensional MRI. Magn Reson Imaging 2005;23:929-937 (Pubitemid 41681673)
72. Hirata K, Yaginuma T, O'Rourke MF, Kawakami M. Age-related changes in carotid artery flow and pressure pulses: possible implications for cerebral microvascular disease. Stroke 2006;37:2552-2556 (Pubitemid 44454678)
73. Hirata K, O'Rourke M, Momomura S. Flow augmentation index as a risk factor for silent lacunar infarction. J Am Coll Cardiol 2008;51(Suppl A):A303.
74. Hirata K, O'Rourke MF. Effect of nitrate on the carotid late systolic flow augmentation - a new strategy against stroke. J. Hypertens 2007;25(suppl 2):S336.
75. Iliopoulos J. The aortic wrap procedure: a surgical method of treating age related aortic dilatation and stiffening. Sydney: University of New South Wales thesis; 2006.
76. Yaginuma T, Avolio A, O'Rourke M, Nichols W, Morgan JJ, Roy P et al. Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res 1986;20:153-160
77. Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Mang K, Morgan JJ et al. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990;11:138-144
78. Asmar RG, London GM, O'Rourke MF, Safar ME, for the REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001;38:922-926
79. London GM, Asmar RG, O'Rourke MF, Safar ME, for the REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004;43:92-99 (Pubitemid 38045921)
80. de Luca N, Mallion JM, O'Rourke MF, O'Brien E, Rahn KH, Trimarco B et al. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. Am J Hypertens 2004;17:660-7.
81. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefits from angiotensin-converting enzyme inhibitor "beyond blood pressure lowering": "beyond blood pressure" or "beyond the brachial artery"? J Hypertens 2005;23:551-556. Erratum J Hypertens 2005;23:993-994
82. Dahlof B, Devereux R, Kjeldsen S, Julius S, Beevers G, de Faire U et al. LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002;359:995-1002.
83. Agabati-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, Smulyan H et al. Central blood pressure measurements and antihypertensive therapy. A consensus document. Hypertension 2007;50:154-160
84. Jiang XJ, O'Rourke MF, Zhang YQ, He XY, Liu LS. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure. J Hypertens 2007;25:1095-1099 (Pubitemid 46573130)
85. Ho K. Effects of ageing on arterial distensibility and left ventricular load in an Australian population. Sydney: University of New South Wales thesis; 1982.
86. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-153
87. Poulter NR, Wedel H, Dahlof B, Sever PS, Beevers DG, Caulfield M, Kjeldsen SE, for the ASCOT Investigators. Role of blood pressure and other variables in the differential cardiovascular events noted in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005;366:907-913
88. Matsui Y, Eguchi K, Shibasaki S, Ishikawa J, Moshidl S, Pickering TG et al. on behalf of the JSM-1 Study Group. Monitoring of the central pulse pressure is useful for detecting cardiac overload during antiadrenergic treatment: the Japan Morning Study 1 study. J Hypertens 2008;26:1928-1934